Two Sigma Advisers’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$448K Sell
123,049
-6,700
-5% -$24.4K ﹤0.01% 1797
2025
Q1
$249K Sell
129,749
-13,400
-9% -$25.7K ﹤0.01% 2056
2024
Q4
$272K Sell
143,149
-44,700
-24% -$84.9K ﹤0.01% 2019
2024
Q3
$248K Buy
187,849
+36,000
+24% +$47.5K ﹤0.01% 1991
2024
Q2
$155K Sell
151,849
-8,100
-5% -$8.26K ﹤0.01% 2261
2024
Q1
$293K Sell
159,949
-7,000
-4% -$12.8K ﹤0.01% 2075
2023
Q4
$207K Sell
166,949
-6,500
-4% -$8.06K ﹤0.01% 2221
2023
Q3
$198K Buy
173,449
+3,100
+2% +$3.53K ﹤0.01% 2100
2023
Q2
$156K Sell
170,349
-48,000
-22% -$43.9K ﹤0.01% 2136
2023
Q1
$122K Buy
218,349
+1,200
+0.6% +$672 ﹤0.01% 2352
2022
Q4
$125K Buy
217,149
+1,200
+0.6% +$692 ﹤0.01% 2269
2022
Q3
$68K Sell
215,949
-25,400
-11% -$8K ﹤0.01% 2351
2022
Q2
$85K Sell
241,349
-98,100
-29% -$34.6K ﹤0.01% 2407
2022
Q1
$244K Sell
339,449
-61,200
-15% -$44K ﹤0.01% 2313
2021
Q4
$905K Buy
400,649
+37,757
+10% +$85.3K ﹤0.01% 1607
2021
Q3
$1.05M Buy
362,892
+3,500
+1% +$10.1K ﹤0.01% 1600
2021
Q2
$1.36M Sell
359,392
-609,753
-63% -$2.31M ﹤0.01% 1495
2021
Q1
$3.28M Buy
969,145
+614,617
+173% +$2.08M 0.01% 1040
2020
Q4
$993K Sell
354,528
-36,068
-9% -$101K ﹤0.01% 1572
2020
Q3
$980K Buy
390,596
+197,995
+103% +$497K ﹤0.01% 1507
2020
Q2
$2.62M Buy
192,601
+164,995
+598% +$2.24M 0.01% 1070
2020
Q1
$209K Buy
+27,606
New +$209K ﹤0.01% 2153
2018
Q3
Sell
-48,400
Closed -$483K 2213
2018
Q2
$483K Sell
48,400
-34,300
-41% -$342K ﹤0.01% 1935
2018
Q1
$788K Sell
82,700
-1,600
-2% -$15.2K ﹤0.01% 1645
2017
Q4
$1.25M Buy
84,300
+5,800
+7% +$86.3K ﹤0.01% 1436
2017
Q3
$1.54M Buy
78,500
+52,200
+198% +$1.03M ﹤0.01% 1334
2017
Q2
$378K Buy
+26,300
New +$378K ﹤0.01% 1887